false
0000912061
0000912061
2026-04-29
2026-04-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
|
April 29, 2026
|
|
Date of Report (Date of earliest event reported)
|
NATURAL HEALTH TRENDS CORP.
(Exact name of registrant as specified in its charter)
|
Delaware
|
001-36849
|
59-2705336
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
609 Deep Valley Drive, Suite 395 Rolling Hills Estates, California, 90274
(Address of principal executive offices, including zip code)
(310) 541-0888
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| |
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| |
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| |
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Exchange Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $0.001 per share
|
NHTC
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
|
Emerging growth company ☐
|
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
|
Item 2.02 Results of Operations and Financial Condition.
On April 29, 2025, Natural Health Trends Corp. issued an earnings release announcing its results for the quarter ended March 31, 2026. The press release is attached hereto as exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
| |
(d)
|
Exhibits.
|
|
| |
|
99.1 |
Press Release of Natural Health Trends Corp. dated April 29, 2026 |
| |
|
104 |
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: April 29, 2026
|
|
NATURAL HEALTH TRENDS CORP.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Timothy S. Davidson
|
|
|
|
|
Timothy S. Davidson
|
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
Exhibit 99.1
Natural Health Trends Reports First Quarter 2026 Financial Results
| |
– |
Hong Kong and China orders stable for the last four quarters despite the difficult economic environment |
| |
– |
Restructuring program generated approximately $300,000 of operating and other margin-related cost savings during the quarter |
| |
– |
Declared a quarterly cash dividend of $0.10 per share |
LOS ANGELES – April 29, 2026 – Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended March 31, 2026.
First Quarter 2026 Financial Highlights
| |
•
|
Revenue of $9.2 million decreased 6% compared to $9.7 million in the fourth quarter of 2025 and declined 14% compared to $10.7 million in the first quarter of 2025.
|
| |
•
|
Operating loss was $474,000 compared to $635,000 in the fourth quarter of 2025 and $345,000 in the first quarter of 2025.
|
| |
•
|
Net loss was $154,000, or $0.02 per diluted share, compared to $588,000, or $0.05 per diluted share, in the fourth quarter of 2025 and net income of $122,000, or $0.01 per diluted share, in the first quarter of 2025.
|
| |
•
|
The number of Active Members1 was 26,400 at March 31, 2026 compared to 26,650 at December 31, 2025 and 30,180 at March 31, 2025.
|
| |
1
|
Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.
|
Management Commentary
“Our business was impacted when trade war rhetoric intensified about a year ago, but we have since stabilized our top line. The operating environment remains challenging amid subdued consumer spending in China. The restructuring program we announced and implemented late last year has lowered our costs, streamlined our organization, and positioned us to capitalize on growth opportunities. At the same time, we remain focused on launching new products and deploying technology tools to support our members and customers and improve our business efficiency and insights,” commented Chris Sharng, President of Natural Health Trends Corp.
Mr. Sharng continued, "We are also looking ahead with great anticipation to our 25th anniversary in Hong Kong later this year, supported by a full calendar of events and brand initiatives leading up to and throughout the celebration as we mark this important milestone in our Company’s history.”
Balance Sheet and Cash Flow
| |
•
|
Net cash used in operating activities was $797,000 in the first quarter of 2026 compared to net cash provided by operations of $484,000 in the first quarter of 2025.
|
| |
•
|
Total cash, cash equivalents and marketable securities were $21.2 million at March 31, 2026, down from $28.9 million at December 31, 2025 due to the repurchase of shares of common stock and dividends paid during the first three months of 2026.
|
| |
•
|
On April 27, 2026, the Company’s Board of Directors declared a quarterly cash dividend of $0.10 on each share of common stock outstanding. The dividend will be payable on May 22, 2026 to stockholders of record as of May 12, 2026.
|
First Quarter 2026 Financial Results Conference Call
Management will host a conference call to discuss the first quarter 2026 financial results today, Wednesday, April 29, 2026 at 11:30 a.m. Eastern Time. The conference call details are as follows:
|
Date:
|
Wednesday, April 29, 2026
|
|
Time:
|
11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
|
|
Dial-in:
|
1-800-330-6730
|
|
Participant ID:
|
402403
|
For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.
About Natural Health Trends Corp.
Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.
Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company's Board of Directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 20, 2026 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
CONTACT:
Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
investor.relations@nhtglobal.com
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)
| |
|
March 31, 2026
|
|
|
December 31, 2025
|
|
| |
|
(Unaudited)
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
9,221 |
|
|
$ |
6,813 |
|
|
Marketable securities
|
|
|
12,010 |
|
|
|
22,060 |
|
|
Inventories
|
|
|
1,971 |
|
|
|
2,047 |
|
|
Other current assets
|
|
|
3,334 |
|
|
|
3,274 |
|
|
Total current assets
|
|
|
26,536 |
|
|
|
34,194 |
|
|
Property and equipment, net
|
|
|
258 |
|
|
|
153 |
|
|
Operating lease right-of-use assets
|
|
|
2,892 |
|
|
|
1,869 |
|
|
Deferred tax asset
|
|
|
288 |
|
|
|
289 |
|
|
Other assets
|
|
|
1,976 |
|
|
|
1,923 |
|
|
Total assets
|
|
$ |
31,950 |
|
|
$ |
38,428 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
1,306 |
|
|
$ |
555 |
|
|
Accrued commissions
|
|
|
1,670 |
|
|
|
1,958 |
|
|
Other accrued expenses
|
|
|
1,234 |
|
|
|
1,438 |
|
|
Deferred revenue
|
|
|
5,001 |
|
|
|
5,574 |
|
|
Amounts held in eWallets
|
|
|
2,739 |
|
|
|
2,838 |
|
|
Operating lease liabilities
|
|
|
958 |
|
|
|
869 |
|
|
Other current liabilities
|
|
|
335 |
|
|
|
456 |
|
|
Total current liabilities
|
|
|
13,243 |
|
|
|
13,688 |
|
|
Deferred tax liability
|
|
|
179 |
|
|
|
180 |
|
|
Operating lease liabilities
|
|
|
2,064 |
|
|
|
1,131 |
|
|
Total liabilities
|
|
|
15,486 |
|
|
|
14,999 |
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
|
Preferred stock
|
|
|
— |
|
|
|
— |
|
|
Common stock
|
|
|
13 |
|
|
|
13 |
|
|
Additional paid-in capital
|
|
|
85,033 |
|
|
|
85,033 |
|
|
Accumulated deficit
|
|
|
(37,448 |
) |
|
|
(36,436 |
) |
|
Accumulated other comprehensive loss
|
|
|
(775 |
) |
|
|
(784 |
) |
|
Treasury stock, at cost
|
|
|
(30,359 |
) |
|
|
(24,397 |
) |
|
Total stockholders’ equity
|
|
|
16,464 |
|
|
|
23,429 |
|
|
Total liabilities and stockholders’ equity
|
|
$ |
31,950 |
|
|
$ |
38,428 |
|
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)
| |
|
Three Months Ended March 31,
|
|
| |
|
2026
|
|
|
2025
|
|
|
Net sales
|
|
$ |
9,206 |
|
|
$ |
10,737 |
|
|
Cost of sales
|
|
|
2,303 |
|
|
|
2,832 |
|
|
Gross profit
|
|
|
6,903 |
|
|
|
7,905 |
|
|
Operating expenses:
|
|
|
|
|
|
|
|
|
|
Commissions expense
|
|
|
3,853 |
|
|
|
4,488 |
|
|
Selling, general and administrative expenses
|
|
|
3,524 |
|
|
|
3,762 |
|
|
Total operating expenses
|
|
|
7,377 |
|
|
|
8,250 |
|
|
Loss from operations
|
|
|
(474 |
) |
|
|
(345 |
) |
|
Other income, net
|
|
|
295 |
|
|
|
465 |
|
|
Income (loss) before income taxes
|
|
|
(179 |
) |
|
|
120 |
|
|
Income tax benefit
|
|
|
(25 |
) |
|
|
(2 |
) |
|
Net income (loss)
|
|
$ |
(154 |
) |
|
$ |
122 |
|
|
Net income (loss) per common share:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
(0.02 |
) |
|
$ |
0.01 |
|
|
Diluted
|
|
$ |
(0.02 |
) |
|
$ |
0.01 |
|
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
10,143 |
|
|
|
11,486 |
|
|
Diluted
|
|
|
10,143 |
|
|
|
11,491 |
|
NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
| |
|
Three Months Ended March 31,
|
|
| |
|
2026
|
|
|
2025
|
|
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(154 |
) |
|
$ |
122 |
|
|
Adjustments to reconcile net income (loss) to net cash used in operating activities:
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization
|
|
|
11 |
|
|
|
30 |
|
|
Net accretion of marketable securities
|
|
|
(29 |
) |
|
|
(113 |
) |
|
Share-based compensation
|
|
|
— |
|
|
|
34 |
|
|
Noncash lease expense
|
|
|
286 |
|
|
|
275 |
|
|
Deferred income taxes
|
|
|
— |
|
|
|
(2 |
) |
|
Changes in assets and liabilities:
|
|
|
|
|
|
|
|
|
|
Inventories
|
|
|
43 |
|
|
|
465 |
|
|
Other current assets
|
|
|
(57 |
) |
|
|
182 |
|
|
Other assets
|
|
|
(58 |
) |
|
|
(154 |
) |
|
Accounts payable
|
|
|
719 |
|
|
|
73 |
|
|
Accrued commissions
|
|
|
(268 |
) |
|
|
(214 |
) |
|
Other accrued expenses
|
|
|
(263 |
) |
|
|
(259 |
) |
|
Deferred revenue
|
|
|
(534 |
) |
|
|
501 |
|
|
Amounts held in eWallets
|
|
|
(80 |
) |
|
|
12 |
|
|
Operating lease liabilities
|
|
|
(294 |
) |
|
|
(281 |
) |
|
Other current liabilities
|
|
|
(119 |
) |
|
|
(187 |
) |
|
Net cash used in operating activities
|
|
|
(797 |
) |
|
|
484 |
|
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Purchases of property and equipment
|
|
|
(115 |
) |
|
|
(16 |
) |
|
Purchases of marketable securities
|
|
|
(1,097 |
) |
|
|
(17,378 |
) |
|
Proceeds from maturities of marketable securities
|
|
|
11,156 |
|
|
|
27,365 |
|
|
Net cash provided by (used in) investing activities
|
|
|
9,944 |
|
|
|
9,971 |
|
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Repurchase of common stock
|
|
|
(5,870 |
) |
|
|
— |
|
|
Dividends paid
|
|
|
(858 |
) |
|
|
(2,303 |
) |
|
Net cash used in financing activities
|
|
|
(6,728 |
) |
|
|
(2,303 |
) |
|
Effect of exchange rates on cash, cash equivalents and restricted cash
|
|
|
(11 |
) |
|
|
3 |
|
|
Net increase (decrease) in cash, cash equivalents and restricted cash
|
|
|
2,408 |
|
|
|
8,155 |
|
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period
|
|
|
6,820 |
|
|
|
13,567 |
|
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period
|
|
$ |
9,228 |
|
|
$ |
21,722 |
|
|
SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:
|
|
|
|
|
|
|
|
|
|
Right-of-use assets obtained in exchange for operating lease liabilities
|
|
$ |
1,339 |
|
|
$ |
79 |
|
|
Direct costs incurred to repurchase common stock
|
|
$ |
92 |
|
|
$ |
— |
|
